Mads Faurby

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)

William H. Polonsky, RIYA ARORA, Mads Faurby et al. · Diabetes Therapy · 2021 · 89 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Insights into the early use of oral semaglutide in routine clinical practice: The <scp>IGNITE</scp> study

Vanita R. Aroda, Mads Faurby, Søren Lophaven et al. · Diabetes Obesity and Metabolism · 2021 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Obesity-related complications, healthcare resource use and weight loss strategies in six European countries: the RESOURCE survey

Marc Evans, Joanna de Courcy, Elisabeth de Laguiche et al. · International Journal of Obesity · 2023 · 46 citations · Full text

Public Health, Maternal Health, Health Assessment +14

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL)

Julien Sénéschal, J.‐P. Lacour, Anthony Bewley et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 35 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals

Jonathan Pearson‐Stuttard, Tania Banerji, Silvia Capucci et al. · International Journal of Obesity · 2023 · 29 citations · Full text

Public Health, Chronic Disease Prevention, Health Assessment +12